Contineum Therapeutics, Inc. Class A (CTNM) Ownership - Who Owns Contineum Therapeutics, Inc. Class A?

223 Followers

Contineum Therapeutics, Inc. Class A (CTNM) Ownership Overview

0.51% Insiders

8.59% Mutual Funds

49.93% Other Institutional Investors

5.23% ETFs

35.75% Public Companies and

Individual Investors

The ownership structure of Contineum Therapeutics, Inc. Class A (CTNM) stock is a mix of institutional, retail, and individual investors. Approximately 63.74% of the company’s stock is owned by Institutional Investors, 0.51% is owned by Insiders, and 35.75% is owned by Public Companies and Individual Investors.

The ownership structure of Contineum Therapeutics, Inc. Class A (CTNM) stock is a mix of institutional, retail, and individual investors. Approximately 58.52% of the company’s stock is owned by Institutional Investors, 0.51% is owned by Insiders, and 5.23% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Jun 30, 2024	Perceptive Advisors Llc	xxxxxxxxxxxxx	$16398032
Jun 30, 2024	Ra Capital Management	xxxxxxxxxxxxx	$16925917

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
Felix Baker	1,420,838	Institution	4.34%	19,025,021
Peter Kolchinsky	1,296,012	Institution	3.96%	17,353,601
Joseph Edelman	1,255,592	Institution	3.84%	16,812,377
	1,183,723	Institution	3.62%	15,850,051
	1,114,886	Institution	3.41%	14,928,324
	676,121	Institution	2.07%	9,053,260
Brad Bolzon	542,628	Institution	1.66%	7,265,789
	450,000	Institution	1.38%	6,025,500
	300,644	Institution	0.92%	4,025,623
	280,000	Institution	0.86%	3,749,200

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,114,886	Institution	3.41%	14,928,324
676,121	Institution	2.07%	9,053,260
450,000	Institution	1.38%	6,025,500
280,000	Institution	0.86%	3,749,200
175,935	Institution	0.54%	2,355,770
49,280	Institution	0.15%	659,859
16,648	Institution	0.05%	222,917
15,969	Institution	0.05%	213,825
13,802	Institution	0.04%	184,809
11,300	Institution	0.03%	151,307

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	910,659	Institution	2.78%	11,893,207
Vanguard Extended Market ETF	273,064	Institution	0.83%	3,566,216
iShares Biotechnology ETF	195,370	Institution	0.60%	2,668,754
Schwab U.S. Small-Cap ETF	117,214	Institution	0.36%	1,599,971
iShares Micro-Cap ETF	62,322	Institution	0.19%	851,319
Dimensional U.S. Small Cap ETF	44,710	Institution	0.14%	610,292
Avantis U.S Small Cap Equity ETF	35,251	Institution	0.11%	481,529
iShares NASDAQ US Biotechnology UCITS ETF	21,476	Institution	0.07%	293,147
Schwab U.S. Broad Market ETF	10,500	Institution	0.03%	143,325
U.S. Micro Cap Portfolio ETF	6,428	Institution	0.02%	98,606

FAQ

Who Owns Contineum Therapeutics, Inc. Class A (CTNM)?

According to the latest TipRanks data, approximately 49.93% of the company's stock is held by institutional investors, 0.51% is held by insiders, and 35.75% is held by retail investors.

What percentage of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by institutional investors?

According to the latest TipRanks data, approximately 49.93% of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by institutional investors.

What percentage of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by retail investors?

According to the latest TipRanks data, approximately 35.75% of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by retail investors.

Who owns the most shares of Contineum Therapeutics, Inc. Class A (CTNM)?

Felix Baker owns the most shares of Contineum Therapeutics, Inc. Class A (CTNM).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.